Literature DB >> 3340316

[Hypopotassemia and rhabdomyolysis. Description of 3 cases of different etiologies].

M C Maresca1, G Calconi, G P Amici, T Teodori, A Da Porto.   

Abstract

Three cases of rhabdomyolysis secondary to hypopotassaemia caused respectively by excess liquorice intake, the use of a nasal spray containing fluoroprednisolone acetate and a kidney tubular condition identified as distal tubular acidosis (ATR) are described. The aetiology of each case is discussed with a description of the clinical course and laboratory tests and particular emphasis on variations in the renin-angiotensin-aldosterone system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3340316

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  5 in total

1.  Licorice abuse: time to send a warning message.

Authors:  Hesham R Omar; Irina Komarova; Mohamed El-Ghonemi; Ahmed Fathy; Rania Rashad; Hany D Abdelmalak; Muralidhar Reddy Yerramadha; Yaseen Ali; Engy Helal; Enrico M Camporesi
Journal:  Ther Adv Endocrinol Metab       Date:  2012-08       Impact factor: 3.565

2.  Surveillance of suspected adverse reactions to herbal products used as laxatives.

Authors:  Annabella Vitalone; Francesca Menniti-Ippolito; Roberto Raschetti; Francesca Renda; Loriana Tartaglia; Gabriela Mazzanti
Journal:  Eur J Clin Pharmacol       Date:  2011-10-02       Impact factor: 2.953

3.  Hypokalemic rhabdomyolysis in a child with Bartter's syndrome.

Authors:  Ivana Pela; Marco Materassi; Daniela Seracini; Giancarlo Lavoratti; Alberto Bettinelli
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

4.  Hypokalemic thyrotoxic periodic paralysis in a Caucasian male with Graves' disease.

Authors:  M F Celani; M E Bonati; M Cavalli
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

5.  A case of rhabdomyolysis with fatal outcome after a treatment with levofloxacin.

Authors:  Fabrice Petitjeans; Julien Nadaud; Jean Paul Perez; Bruno Debien; Frederic Olive; Thierry Villevieille; Bruno Pats
Journal:  Eur J Clin Pharmacol       Date:  2003-10-24       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.